Â鶹´«Ã½

Any examples are for illustrative purposes only.

Â鶹´«Ã½ is aware of the substantial impact Hurricane Helene had on the IV solution supply chain. These impacts will likely continue for some time as alternate manufacturing options are determined. ÌýÂ鶹´«Ã½ understands the impact these shortages can have on patient care and overall operations.Ìý Â鶹´«Ã½ encourages organizations to implement conservation strategies for these shortages. Healthcare organizations must ensure that implemented conservation strategies preserve patient safety.Ìý The American Society of Health-System Pharmacy (ASHP) website has strategies for consideration and those can be found at

Â鶹´«Ã½ has received questions from organizations regarding the ability to circumvent long standing guidance from both Centers for Disease Control (CDC) or the Food and Drug Administration (FDA). As an accreditation organization, the Joint Commission does not have the ability to alter federal guidelines from CDC or the FDA related to sterile medications.Ìý However, Â鶹´«Ã½ will ensure that none of our accreditation standards preclude healthcare organizations from adopting any interim guidance provided by the CDC or FDA (for example, use of FDA-approved imported sterile medications, or FDA-approved extended expiration dating).Ìý

Additional Resources:

Ìý